Plain-English translation of NCT07491445 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This is a large international study testing a new medication called for people with advanced pancreatic cancer that has spread to other parts of the body. You would receive either the medication alone, the medication combined with standard chemotherapy drugs, or standard chemotherapy alone. The researchers want to see whether adding this treatment helps people live longer and delays cancer growth.
Pancreatic cancer that has spread is very difficult to treat, and current chemotherapy options have limited effectiveness. This trial is testing whether this new medication can improve survival by targeting specific changes in cancer cells.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of three groups: receiving the new medication alone, the new medication combined with standard chemotherapy, or standard chemotherapy alone. You will have regular visits with doctors for blood tests, imaging scans, and check-ups to monitor how you are responding and any side effects. The study will track how long you survive and how well your cancer responds to treatment.
AI-generated summary from trial data · Oct 2, 2026 · Not medical advice
United States